During the past decade, Dr. Susan Love Research Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Susan Love Research Foundation" #1 collaborator was "Covance" with 1 trials as a collaborator and "Illumina, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Susan Love Research Foundation" are "Breast Cancer" (2 trials), "Ductal Carcinoma in Situ" (1 trials) and "Preneoplastic Conditions" (1 trials). Many other conditions were trialed in "Dr. Susan Love Research Foundation" in a lesser frequency.

Most popular intervention types in "Dr. Susan Love Research Foundation" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood draw" (1 trials), "Ductal lavage microcatheter" (1 trials) and "Nipple aspirator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Susan Love Research Foundation" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dr. Susan Love Research Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr. Susan Love Research Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Susan Love Research Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".